Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymosin beta-4, Y-chromosomal is a small, 44–amino acid protein encoded by the TMSB4Y gene located in the male-specific region of the human Y chromosome[4][5]. It is a member of the beta-thymosin family, which also includes the X-chromosomal thymosin beta-4 (TMSB4X)[5]. Thymosin beta-4, Y-chromosomal functions as an actin-binding protein, primarily responsible for **sequestering actin monomers and regulating actin polymerization** in the cytoplasm, thus participating in the organization and dynamic remodeling of the cytoskeleton[4][5]. It shares sequence similarity and biological properties with its X-chromosomal counterpart, but is distinct in being Y-linked and male specific[5]. No direct evidence supports its role as a therapeutic target, nor are there known disease associations uniquely attributed to this protein or any interacting drugs or biomarker utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymosin beta-4, Y-chromosomal (TMSB4Y).